RNA markers can inform personalized treatment strategies by identifying specific molecular characteristics of a patient's cancer. For example, the presence of certain RNA markers may indicate sensitivity to targeted therapies or resistance to standard treatments. By tailoring treatments based on RNA marker profiles, clinicians can improve treatment efficacy and minimize adverse effects.